■ Updates in diagnosis and treatment of acromegaly
Roula Zahr, Maria Fleseriu
Eur Endocrinol. 2018 Sep; 14(2): 57–61
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182922/
■ Insulin resistance in patients with acromegaly
Greisa Vila, Jens Otto L. Jørgensen, Anton Luger, Günter K. Stalla
Front Endocrinol (Lausanne) 2019; vol 10: 509
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683662/
■ Neoplasias malignas en acromegalia
S Sosa, K Danilowicz, R M Gómez
Rev Argent Endocrinol Metab 2018, vol 55 (4): 240-246
http://www.raem.org.ar/numeros/2018-vol55/numero-04/vol55-04-006.pdf
■ Hearing Loss in Acromegaly – A Review
Teixeira, Liane Sousa et al.
Int. Arch. Otorhinolaryngol., July 2018, vol.22, no.3, p.313-316
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1809-48642018000300313&lng=en&nrm=iso
■ Bringing cardiovascular comorbidities in acromegaly to an update. How should we diagnose and manage them?
Ana M. Ramos-Leví, Mónica Marazuela
Front Endocrinol (Lausanne) 2019; vol 10: 120.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423916/
■ Hepatic steatosis in patients with acromegaly
Andreani Koutsou‐Tassopoulou, Ifigeneia Papapostoli‐Sklavounou, Marcin Krawczyk, et al
Endocrinol Diabetes Metab. 2019 Oct; 2(4): e00090
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775446/
■ The endothelium in acromegaly
Pietro Maffei, Francesca Dassie, Alexandra Wennberg, et al
Front Endocrinol (Lausanne) 2019; vol 10: 437
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667653/
■ Actions of pituitary hormones beyond traditional targets
Mone Zaidi, Maria I. New, Harry C. Blair et al
J Endocrinol. 2018 Jun; 237(3): R83–R98
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924585/
■ Emerging and novel treatments for pituitary tumors
Mirela Diana Ilie, Hélène Lasolle, Gérald Raverot
J Clin Med. 2019, vol 8(8): 1107
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723109/
■ Pediatric pituitary adenoma: case series, review of the literature, and a skull base treatment paradigm
Avital Perry, Christopher Salvatore Graffeo, Christopher Marcellino et a
J Neurol Surg B Skull Base. 2018 Feb; 79(1): 91–114
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796823/
■ Pituitary disease in pregnancy: special aspects of diagnosis and treatment
Stephan Petersenn, Mirjam Christ-Crain, Michael Droste et al
Geburtshilfe Frauenheilkd. 2019, vol 79(4): 365–374
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461462/
■ Hypopituitarism after orthohantavirus infection: What is currently known?
Soerajja Bhoelan, Thomas Langerak, Danny Noack, et al
Viruses. 2019, vol 11(4): 340
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521286/
■ Neonatal hypopituitarism: approaches to diagnosis and treatment
Selim Kurtoğlu, Ahmet Özdemir, Nihal Hatipoğlu
J Clin Res Pediatr Endocrinol. 2019, vol 11(1): 4–12
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398195/
■ Staging and managing patients with acromegaly in clinical practice: baseline data from the SAGIT validation study
A Giustina, M D Bronstein, P Chanson et al
Pituitary 2019, vol 22 (5): 476-487
https://link.springer.com/article/10.1007/s11102-019-00977-5
■ Clinical and hormonal characteristics of patients with different types of hypophysitis: a single-center experience
Imga, Narin Nasiroglu et al.
Arch. Endocrinol. Metab., Jan 2019, vol.63, no.1, p.47-52
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972019000100047&lng=en&nrm=iso
■ Combined pituitary hormone deficiency caused by PROP1 mutations: update 20 years post-discovery
F A Correa, M Nakagurna, J L O Madeira et al
Arch Endocrinol Metab 2019, vol63 (2)
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972019000200167
■ Clinical and pathological aspects of silent pituitary adenomas
Juliana Drummond, Federico Roncaroli, Ashley B Grossman, Márta Korbonits
J Clin Endocrinol Metab. 2019, vol 104(7): 2473–2489
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517166/
■ Functionin pituitary adenomas – current treatment options and emerging medical therapies
Elena V Varlamov, Shirley McCartney, Maria Fleseriu
Eur Endocrinol. 2019 Apr; 15(1): 30–40.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587904/
■ Non-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management
Daniela Esposito, Daniel S. Olsson, Oskar Ragnarsson et al
Pituitary. 2019; vol 22(4): 422–434
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647426/
■ Prolactina como immunomodulador en las enfermidades autoimunes
C Pissoni, L Nieto, m Raã et al
Rev Argent Endocrinol Metab 2019, vol 56#2
http://www.raem.org.ar/numeros/2019-vol56/numero-02/raem-56-2-43-48.pdf
■ Serum prolactina and bone mineral density in schizophrenia: a systematic review
John Lally, Abdullah Bin Sahl, Kieran C. Murphy et al
Clin Psychopharmacol Neurosci. 2019, vol 17(3): 333–342
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705095/
■ Serum prolactina overestimation and risk of misdiagnosis
Sunita M.C. De Sousa, Mohamed Saleem, Wayne Rankin, David J. Torpy
Endocrinol Diabetes Metab. 2019, vol 2(3): e00065.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613232/
■ A systematic review of cortisol, thyroid stimulating hormone and prolactin in periperipartum women with major depression
Mercedes J. Szpunar, Barbara L. Parry
Arch Womens Ment Health. 2018 Apr; 21(2): 149–161
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857206/
■ Prolactin concentration in various stages of endometriosis in infertile women
Parvaneh Mirabi, Seyede Hanie Alamolhoda, Masoumeh Golsorkhtabaramiri, Mahshid Namdari, Sedighe Esmaeilzadeh
JBRA Assist Reprod. 2019, vol 23(3): 225–229
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724390/
■ Clinical manifestations, evaluation and management of hyperprolactinemia in adolescent and young girls: a brief review
Matalliotakis Michail, Koliarakis Ioannis, Matalliotaki Charoula, Trivli Alexandra, Hatzidaki Eleftheria
Acta Biomed. 2019; vol 90(1): 149–157
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502148/
■ PCOS and hyperprolactinemia: What do we know in 2019
Clémence Delcour, Geoffroy Robin, Jacques Young, Didier Dewailly
Clin Med Insights Reprod Health. 2019; 13: 1179558119871921
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734626/
■ Stress-induced hyperprolactinemia: pathophysiology and clinical approach
Samara Levine, Ozgul Muneyyirci-Delale
Obstet Gynecol Int. 2018; 2018: 9253083.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304861/
■ Genetic causes of isolated short stature
Vasques, Gabriela A., Andrade, Nathalia L. M. and Jorge, Alexander A. L
Arch. Endocrinol. Metab., Jan 2019, vol.63, no.1, p.70-7
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972019000100070
■ Growth hormone deficiency following traumatic brain injury
Oratile Kgosidialwa, Osamah Hakami, Hafiz Muhammad Zia-Ul-Hussnain, Amar Agha
Int J Mol Sci. 2019, vol 20(13): 3323
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651180/
■ Growth hormone (GH) therapy during the transition period: Should we think about early retesting in patiens with idiopathic and isolated GH deficiency?
Laura Penta, Marta Cofini, Laura Lucchetti et al
Int J Environ Res Public Health. 2019, vol 16(3): 30
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388362/
■ Targeting growth hormone function: strategies and therapeutic applications
Man Lu, Jack U. Flanagan, Ries J. Langley, Michael P. Hay, Jo K. Perry
Signal Transduct Target Ther. 2019; 4: 3
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367471/
■ The potential effects of anabolic-androgenic steroids and growth hormone as commonly used sport supplements on the kidney: a systematic review
Dorna Davani-Davari, Iman Karimzadeh, Hossein Khalili
BMC Nephrol. 2019; vol 20: 198
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545019/
■ Use of growth hormone in the IVF treatment of women with poor ovarian reserve
Roger J. Hart
Front Endocrinol (Lausanne) 2019; vol 10: 500
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667844/
■ Dr Paulo Fernando Leite
Cardiologia/Prevenção Cardiovascular
Estratificação de Risco Cardiovascular
Consultório: Rua Padre Rolim 815/sala 601
Tel: 33245518
CRMMG: 7026
Email: pfleite1873@gmail.com
Data: nov 2019